1 – Scheme overview

The scheme is designed to assess the performance of different serological tests for Lyme disease: IgG/IgM screening tests and IgG/IgM confirmation tests.

Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the scheme.

2 – Assessment frequency

Number of investigations per year: 4
Number of control samples per investigation: 1 or 2
Number of samples per year: 6

3 – List of tests assessed

• IgG screening test
• IgM screening test
• IgG confirmation test
• IgM confirmation test

4 – Description of the control samples

Lyophilized human control serums (samples to be resuspended in 1 mL of distilled water).

5 - Clinical settings

The clinical setting for the samples to be tested during each investigation is systematically described and participating labs are encouraged to propose a global interpretation of the results obtained. This interpretation is also commented in the reports.